| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Head Of R&D | Chief Medical Officer
3 companies
Dupont Jakob is an EVP, Head Of R&D at Atara Biotherapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sell | 5,074 | $3.63 | $18,403.40 | -1.7% | -57.3% | -78.5% | |
| Nov 16, 2022 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sell | 4,342 | $4.49 | $19,496.70 | -1.4% | +1.5% | -89.5% | |
| Aug 16, 2022 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sell | 4,124 | $5.03 | $20,760.22 | -2.5% | +4.9% | -65.8% | |
| May 17, 2022 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sell | 3,873 | $5.32 | $20,596.61 | -2.3% | -4.5% | -63.1% | |
| Mar 1, 2022 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sell | 2,221 | $9.86 | $21,890.18 | -1.3% | -49.1% | -61.7% | |
| Feb 10, 2022 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sale+OE | 5,000 | $16.00 | $80,000.00 | -5.2% | -66.7% | -71.6% | |
| Jan 3, 2022 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sale+OE | 5,000 | $16.01 | $80,050.00 | -5.2% | -41.7% | -80.6% | |
| Dec 1, 2021 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sale+OE | 5,000 | $17.94 | $89,688.50 | -5.2% | -41.2% | -74.7% | |
| Nov 16, 2021 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sell | 2,199 | $17.12 | $37,640.06 | -2.4% | -18.0% | -73.7% | |
| Nov 2, 2021 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sale+OE | 5,000 | $16.41 | $82,050.00 | -5.1% | -11.5% | -73.1% |